Detection of Bladder Cancer Cells in Surgical Smoke During Robot-Assisted Radical Cystectomy: Findings from a Prospective Study - Scorecard - MDSpire

Detection of Bladder Cancer Cells in Surgical Smoke During Robot-Assisted Radical Cystectomy: Findings from a Prospective Study

  • By

  • Kosuke Shibamori

  • Kohei Hashimoto

  • Ko Okabe

  • Takeshi Maehana

  • Tetsuya Shindo

  • Yuki Kyoda

  • Ko Kobayashi

  • Toshiaki Tanaka

  • Satoshi Takahashi

  • Naoya Masumori

  • March 18, 2026

  • 0 min

Share

Clinical Scorecard: Detection of Bladder Cancer Cells in Surgical Smoke During Robot-Assisted Radical Cystectomy: Findings from a Prospective Study

At a Glance

CategoryDetail
Condition
Key MechanismsSurgical smoke was analyzed but no cancer cells or associated genes were detected.
Target Population
Care Setting

Key Highlights

  • No bladder cancer cells or associated genes detected in surgical smoke during RARC.
  • Study involved 28 patients with a median age of 73 years.
  • Exosome levels in surgical smoke were significantly lower than in control samples, but no cancer cells or genes were found.

Guideline-Based Recommendations

Diagnosis

    Management

      Monitoring & Follow-up

        Risks

        • P
        • o
        • t
        • e
        • n
        • t
        • i
        • a
        • l
        • f
        • o
        • r
        • c
        • a
        • n
        • c
        • e
        • r
        • c
        • e
        • l
        • l
        • d
        • i
        • s
        • s
        • e
        • m
        • i
        • n
        • a
        • t
        • i
        • o
        • n
        • v
        • i
        • a
        • s
        • u
        • r
        • g
        • i
        • c
        • a
        • l
        • s
        • m
        • o
        • k
        • e
        • r
        • e
        • m
        • a
        • i
        • n
        • s
        • u
        • n
        • p
        • r
        • o
        • v
        • e
        • n
        • ,
        • a
        • s
        • p
        • e
        • r
        • s
        • t
        • u
        • d
        • y
        • f
        • i
        • n
        • d
        • i
        • n
        • g
        • s
        • .

        Patient & Prescribing Data

        Patients undergoing RARC for MIBC.

        Neoadjuvant chemotherapy was administered to 46% of participants.

        Clinical Best Practices

        • Utilize digital PCR for mutation detection in surgical samples, as it was ineffective in this study.
        • Implement water trap systems for capturing surgical smoke, which were used in the study.

        References

        Original Source(s)

        Related Content